New Report: The Business of Wellness, Recovery & Longevity
Explore the trends shaping the future of wellness.
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
This week, we break down more good news for America's big-box gyms, and look into the complexities surrounding the U.S.'s obesity crisis.
While obesity rates have fallen in some U.S. States, researchers warn that current definitions don't paint a full picture of America's weight crisis.
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
Under a new definition of obesity endorsed by the The American Heart Association, 70% of Americans are obese, up from 40% currently.
The AI-powered Simple Life app ditches calorie counting in favor of data-driven coaching, gamification and habit science.
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Rebel Wilson joins Noom as chief wellness ambassador, backing its new free tier that gamifies healthy habits and spotlights microdose GLP-1s.
FuturHealth, a provider of weight-loss solutions including GLP-1s, will offer Apple Fitness+ at no additional cost to its members.
Sign Up to Our Newsletter
